Literature DB >> 20359968

Update on primary biliary cirrhosis.

Pietro Invernizzi1, Carlo Selmi, M Eric Gershwin.   

Abstract

Primary biliary cirrhosis is an autoimmune chronic liver disease characterized by progressive bile duct destruction eventually leading to cirrhosis, liver failure, and death. The autoimmune pathogenesis is supported by a plethora of experimental and clinical data, such as the presence of autoreactive T cells and serum autoantibodies. The aetiology remains unknown, although evidence suggests a role for both genetic susceptibility and environmental factors that remain to be determined. In fact, a number of chemicals and infectious agents have been proposed to induce the disease in predisposed individuals. The recent availability of several murine models will significantly help in understanding pathophysiology mechanisms. In this review, we critically summarize the most recent data on the aetiopathogenesis of primary biliary cirrhosis, discuss the latest theories and developments, and suggest directions for future research. Copyright 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359968      PMCID: PMC2871061          DOI: 10.1016/j.dld.2010.02.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  114 in total

Review 1.  Molecular mimicry and primary biliary cirrhosis: premises not promises.

Authors:  J Van de Water; H Ishibashi; R L Coppel; M E Gershwin
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

2.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

4.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 5.  Definition of human autoimmunity--autoantibodies versus autoimmune disease.

Authors:  Ana Lleo; Pietro Invernizzi; Bin Gao; Mauro Podda; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-04       Impact factor: 9.754

Review 6.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

7.  Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.

Authors:  January T Salas; Jesús M Banales; Sarai Sarvide; Sergio Recalde; Alex Ferrer; Iker Uriarte; Ronald P J Oude Elferink; Jesús Prieto; Juan F Medina
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

8.  Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.

Authors:  Monica Miozzo; Carlo Selmi; Barbara Gentilin; Francesca R Grati; Silvia Sirchia; Sabine Oertelt; Massimo Zuin; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  The genetic basis of primary biliary cirrhosis: premises, not promises.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

10.  Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.

Authors:  Willy Hsu; Weici Zhang; Koichi Tsuneyama; Yuki Moritoki; William M Ridgway; Aftab A Ansari; Ross L Coppel; Zhe-Xiong Lian; Ian Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

View more
  29 in total

1.  Primary biliary cirrhosis: bad genes, bad luck.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Dig Dis Sci       Date:  2012-03       Impact factor: 3.199

2.  Towards common denominators in primary biliary cirrhosis: the role of IL-12.

Authors:  Ana Lleo; M Eric Gershwin; Alberto Mantovani; Pietro Invernizzi
Journal:  J Hepatol       Date:  2011-10-15       Impact factor: 25.083

Review 3.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

Review 4.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

Authors:  Brian D Juran; Gideon M Hirschfield; Pietro Invernizzi; Elizabeth J Atkinson; Yafang Li; Gang Xie; Roman Kosoy; Michael Ransom; Ye Sun; Ilaria Bianchi; Erik M Schlicht; Ana Lleo; Catalina Coltescu; Francesca Bernuzzi; Mauro Podda; Craig Lammert; Russell Shigeta; Landon L Chan; Tobias Balschun; Maurizio Marconi; Daniele Cusi; E Jenny Heathcote; Andrew L Mason; Robert P Myers; Piotr Milkiewicz; Joseph A Odin; Velimir A Luketic; Bruce R Bacon; Henry C Bodenheimer; Valentina Liakina; Catherine Vincent; Cynthia Levy; Andre Franke; Peter K Gregersen; Fabrizio Bossa; M Eric Gershwin; Mariza deAndrade; Christopher I Amos; Konstantinos N Lazaridis; Michael F Seldin; Katherine A Siminovitch
Journal:  Hum Mol Genet       Date:  2012-08-29       Impact factor: 6.150

Review 6.  Impact of microbes on autoimmune diseases.

Authors:  Claudia Danzer; Jochen Mattner
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-16       Impact factor: 4.291

7.  Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Authors:  Jesús M Banales; Elena Sáez; Miriam Uriz; Sarai Sarvide; Aura D Urribarri; Patrick Splinter; Pamela S Tietz Bogert; Luis Bujanda; Jesús Prieto; Juan F Medina; Nicholas F LaRusso
Journal:  Hepatology       Date:  2012-07-10       Impact factor: 17.425

Review 8.  Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Authors:  Pietro Invernizzi
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

Review 9.  The otherness of self: microchimerism in health and disease.

Authors:  J Lee Nelson
Journal:  Trends Immunol       Date:  2012-05-19       Impact factor: 16.687

Review 10.  Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis.

Authors:  Marco Carbone; Ana Lleo; Richard N Sandford; Pietro Invernizzi
Journal:  Eur J Immunol       Date:  2014-02-27       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.